Ethanol Impairs Insulin's Actions Through Phosphatidylinositol 3-Kinase

Journal of Medicinal Food

Volumn 7, Issue 1, 2004, Pages 24-30

  Yi, Sun Ju ^a   Jhun, Byung H ^a  

^a Pusan National University   (South Korea)

Author keywords

C Jun expression; DNA synthesis; Ethanol; Glucose transport; Insulin; Phosphatidylinositol 3 kinase

Indexed keywords

ALCOHOL; DNA; GLUCOSE; GLUTATHIONE TRANSFERASE; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C JUN; TROGLITAZONE; TYROSINE;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ASSAY; ENZYME SUBUNIT; FIBROBLAST; GLUCOSE TRANSPORT; HORMONE ACTION; INSULIN RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ADIPOCYTES; ANIMALS; DNA; ETHANOL; FIBROBLASTS; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; INSULIN; INSULIN ANTAGONISTS; MICE; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RECEPTOR, INSULIN;

ANIMALIA;

EID: 1842423809     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/109662004322984662     Document Type: Article

References (41)

1. Holbrook TL, Barrett-Connor E, Wingard DL: A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol 1990;132:902-909.
2. Lindegard B, Langman MJ: Marital state, alcohol consumption, and liability to myocardial infarction, stroke, diabetes mellitus, or hypertension in men from Gothenburg. Br Med J (Clin Res Ed) 1985;291:1529-1533.
3. Christiansen C, Thomsen C, Rasmussen O, Hansen C, Hermansen K: The acute impact of ethanol on glucose, insulin, triacylglycerol, and free fatty acid responses and insulin sensitivity in type 2 diabetes. Br J Nutr 1996;76:669-675.
4. Shelmet JJ, Reichard GA, Skutches CL, Hoeldtke RD, Owen OE, Boden G: Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance. J Clin Invest 1988; 81:1137-1145.
5. Yki-Jarvinen H, Nikkila EA: Ethanol decreases glucose utilization in healthy man. J Clin Endocrinol Metab 1985;61:941-945.
6. Risinger FO, Cunningham CL: Genetic differences in ethanol-induced hyperglycemia and conditioned taste aversion. Life Sci 1992;50:PL113-P118.
7. Lomeo F, Khokher MA, Dandona P: Ethanol and its novel metabolites inhibit insulin action on adipocytes. Diabetes 1988; 37:912-915.
8. Rifkin RM, Todd WW, Toothaker DR, Sussman A, Trowbridge M, Draznin B: Effects of in vivo and in vitro alcohol administration on insulin binding and glycogenesis in isolated rat hepatocytes. Ann Nutr Metab 1983;27:313-319.
9. Cook RT, Keiner JA, Yen A: Ethanol causes accelerated G1 arrest in differentiating HL-60 cells. Alcohol Clin Exp Res 1990; 14:695-703.
10. Lizcano JM, Alessi DR: The insulin signalling pathway. Curr Biol 2002;12:R236-R238.
11. Johnson GL, Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-1912.
12. 2-terminal kinase/stress-activated protein kinase by insulin. Biochemistry 1996;35:8769-8775.
13. Burgering BM, Medema RH, Maassen JA, van de Wetering ML, van der Eb AJ, McCormick F, Bos JL: Insulin stimulation of gene expression mediated by p21ras activation. EMBO J 1991;10: 1103-1109.
14. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS: A central role for JNK in obesity and insulin resistance. Nature 2002;420:333-336.
15. Jhun BH, Meinkoth JL, Leitner W, Draznin B, Olefsky JM, Klein RF, Carlos AS: Insulin and insulin-like growth factor-I signal transduction requires p21ras. J Biol Chem 1994;269:5699-5704.
16. Jhun BH, Haruta T, Meinkoth JL, Leitner W, Draznin B, Saltiel AR, Pang L, Sasaoka T, Olefsky JM: Signal transduction pathways leading to insulin-induced early gene. Biochemistry 1995; 34:7996-8004.
17. Butler AP, Martinez LA, Montgomery RL: Involvement of a pertussis-toxin sensitive G protein in the induction of gene expression by insulin. Cell Signal 1996;8:475-480.
18. Xu YY, Bhavani K, Wands JR, de la Monte SM: Ethanol inhibits insulin receptor substrate-1 tyrosine phosphorylation and insulin-stimulated neuronal thread protein gene expression. Biochem J 1995;310:125-132.
19. Saso K, Moehren G, Higashi K, Hoek JB: Differential inhibition of epidermal growth factor signaling pathways in rat hepatocytes by long-term ethanol treatment. Gastroenterology 1997;112: 2073-2088.
20. Mohr L, Tanaka S, Wands JR: Ethanol inhibits hepatocyte proliferation in insulin receptor substrate 1 transgenic mice. Gastroenterology 1998;115:1558-1565.
21. Zhang FX, Rubin R, Rooney TA: N-Methyl-D-aspartate inhibits apoptosis through activation of phosphatidylinositol 3-kinase in cerebellar granule neurons. A role for insulin receptor substrate-1 in the neurotrophic action of N-methyl-D-aspartate and its inhibition by ethanol. J Biol Chem 1998;273:26596-26602.
22. Patel BC, D'Arville C, Iwahashi M, Simon FR: Impairment of hepatic insulin receptors during chronic ethanol administration. Am J Physiol 1991;261:G199-G205.
23. Zhang BH, Farrell GC: Chronic ethanol consumption disrupts complexation between EGF receptor and phospholipase C-gamma 1: relevance to impaired hepatocyte proliferation. Biochem Biophys Res Commun 1991;257:89-94.
24. Resnicoff M, Sell C, Ambrose D, Baserga R, Rubin R: Ethanol inhibits the autophosphorylation of the insulin-like growth factor I (IGF-1) receptor and IGF-1-mediated proliferation of 3T3 cells. J Biol Chem 1993;268:21777-21782.
25. Kiss Z, Anderson WH, Mukherjee JJ: Ethanol potentiates the stimulatory effects of insulin and phosphocholine on mitogenesis by a zinc-dependent and rapamycin-sensitive mechanism in fibroblasts and JB6 cells. Biochem J 1998;330:819-826.
26. White MF: IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 2002;283:E413-E422.
27. Carpenter G: Receptor tyrosine kinase substrates: src homology domains and signal transduction. FASEB J 1992;6:3283-3289.
28. Saltiel AR, Olefsky JM: Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996;45: 1661-1669.
29. Ghazzi MN, Perez JE, Antonucci TK, Driscoll JH, Huang SM, Faja BW, Whitcomb RW: Cardiac and glycemic benefits of troglitazone treatment in NIDDM. The Troglitazone Study Group. Diabetes 1997;46:433-439.
30. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA: An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995;270:12953-12956.
31. Wilson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliever SA, Lehmann JM: The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem 1996;39:665-668.
32. Braissant O, Fouffelle F, Scott C, Dauce M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996;137:354-366.
33. Tontonoz P, Hu E, Graves RA, Budavari AB, Spiegelman BM: mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994;8:1224-1234.
34. Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman BM, Flier JS, Moller DE: Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 1996;97:2553-2561.
35. Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H: Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats. Diabetes 1988;37: 1549-1558.
36. Lee MK, Olefsky JM: Acute effects of troglitazone on in vivo insulin action in normal rats. Metabolism 1995;44:1166-1169.
37. Okuno A, Ikeda K, Shiota M, Fujiwara T, Yoshioka S, Sugano T, Horikoshi H: Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb. Metabolism 1997;46:716-721.
38. Furnsinn C, Neschen S, Noe C, Bisschop M, Roden M, Vogl C, Schneider B, Waldhausl W: Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro. Br J Pharmacol 1997;122:1367-1374.
39. Fulgencio JP, Kohl C, Girard J, Pegorier JP: Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats. Diabetes 1996;45:1556-1562.
40. Inoue I, Katayama S, Takahashi K, Negishi K, Miyazaki T, Sonoda M, Komoda T: Troglitazone has a scavenging effect on reactive oxygen species. Biochem Biophys Res Commun 1997; 235:113-116.
41. Mufti SI, Eskelson CD, Odeleye OE, Nachiappan V: Alcohol-associated generation of oxygen free radicals and tumor promotion. Alcohol Alcohol 1993;28:621-628.